Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Safety and efficacy of once-daily dexfadrostat phosphate in patients with primary aldosteronism: a randomised, parallel group, multicentre, phase 2 trial.
Journal: EClinicalMedicine
Published: January 09, 2024
Structural and clinical characterization of CYP11B2 inhibition by dexfadrostat phosphate.
Journal: The Journal of steroid biochemistry and molecular biology
Published: June 06, 2023
CYP11B2 inhibitor dexfadrostat phosphate suppresses the aldosterone-to-renin ratio, an indicator of sodium retention, in healthy volunteers.
Journal: British journal of clinical pharmacology
Published: July 29, 2022
Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy.
Journal: Journal of hypertension
Published: October 11, 2013
Showing 1-4 of 4
Last Updated: 09/26/2026